Parvez Mantry

5.9k total citations · 1 hit paper
83 papers, 2.1k citations indexed

About

Parvez Mantry is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Parvez Mantry has authored 83 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hepatology, 44 papers in Epidemiology and 26 papers in Surgery. Recurrent topics in Parvez Mantry's work include Liver Disease Diagnosis and Treatment (35 papers), Hepatitis C virus research (25 papers) and Liver Disease and Transplantation (22 papers). Parvez Mantry is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Hepatitis C virus research (25 papers) and Liver Disease and Transplantation (22 papers). Parvez Mantry collaborates with scholars based in United States, Spain and United Kingdom. Parvez Mantry's co-authors include Eric Lawitz, Adel Bozorgzadeh, Ling Han, Robert P. Myers, Mark S. Orloff, Anna Mae Diehl, Michael Charlton, Nezam H. Afdhal, Rohit Loomba and John G. McHutchison and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Parvez Mantry

77 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

2017 435 citations Parvez Mantry et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Parvez Mantry United States	23	1.5k	1.4k	513	196	161	83	2.1k
Georg Semmler Austria	24	940 0.6×	1.2k 0.8×	406 0.8×	256 1.3×	71 0.4×	141	1.7k
Bart J. Veldt Netherlands	19	2.4k 1.6×	2.5k 1.8×	208 0.4×	183 0.9×	110 0.7×	42	3.0k
Sae Hwan Lee South Korea	24	1.2k 0.8×	962 0.7×	602 1.2×	61 0.3×	79 0.5×	106	2.1k
Soon Ho Um South Korea	23	1.1k 0.7×	1.1k 0.8×	377 0.7×	71 0.4×	63 0.4×	68	1.7k
Do Young Kim South Korea	31	2.4k 1.6×	2.4k 1.7×	382 0.7×	85 0.4×	112 0.7×	111	3.0k
Laurentius A. Lesmana Indonesia	19	2.0k 1.3×	2.3k 1.6×	491 1.0×	309 1.6×	100 0.6×	61	2.7k
Bernhard Scheiner Austria	29	1.8k 1.2×	1.6k 1.2×	580 1.1×	125 0.6×	102 0.6×	147	2.5k
Όλγα Γιουλεμέ Greece	24	431 0.3×	811 0.6×	613 1.2×	294 1.5×	60 0.4×	90	1.7k
Teiji Kuzuya Japan	27	1.5k 1.0×	1.3k 0.9×	324 0.6×	92 0.5×	79 0.5×	132	2.2k
Chhagan Bihari India	27	1.0k 0.7×	1.1k 0.8×	501 1.0×	144 0.7×	102 0.6×	132	1.9k

Countries citing papers authored by Parvez Mantry

Since Specialization

Citations

This map shows the geographic impact of Parvez Mantry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parvez Mantry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parvez Mantry more than expected).

Fields of papers citing papers by Parvez Mantry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parvez Mantry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parvez Mantry. The network helps show where Parvez Mantry may publish in the future.

Co-authorship network of co-authors of Parvez Mantry

This figure shows the co-authorship network connecting the top 25 collaborators of Parvez Mantry. A scholar is included among the top collaborators of Parvez Mantry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parvez Mantry. Parvez Mantry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bowlus, Christopher L., Douglas Thorburn, Stephen T. Barclay, et al.. (2025). Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study. The American Journal of Gastroenterology.

Hassanein, Tarek, Andrew P. Keaveny, Parvez Mantry, et al.. (2024). Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Alimentary Pharmacology & Therapeutics. 60(2). 246–256. 10 indexed citations

Bruno, Benjamin, Joshua C. Weavil, Nachiappan Chidambaram, et al.. (2024). Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial. Hepatology. 81(6). 1764–1775. 5 indexed citations

Macarulla, Teresa, Takashi Mizuno, Giovanni Brandi, et al.. (2024). FOENIX-CCA4: A phase 2 study of futibatinib 20 mg and 16 mg in patients with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor 2 (FGFR2) fusions/rearrangements.. Journal of Clinical Oncology. 42(3_suppl). TPS572–TPS572. 2 indexed citations

Mantry, Parvez, et al.. (2023). S1555 Liver Frailty Index is a Significant Predictor of Mortality in Patients Needing Liver Transplantation: A Retrospective Large Single Center Analysis. The American Journal of Gastroenterology. 118(10S). S1175–S1175. 1 indexed citations

Sheikh, Sarah, et al.. (2021). Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center. Journal of Gastrointestinal Oncology. 12(4). 1718–1731. 4 indexed citations

Murray, Anne R., et al.. (2020). Morphological Characteristics of Biliary Strictures after Liver Transplantation Visualized Using SpyGlass™ Cholangioscopy. SHILAP Revista de lepidopterología. 2020. 1–6. 3 indexed citations

Noureddin, Mazen, Naim Alkhouri, Eduardo Vilar‐Gómez, et al.. (2020). Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis. Gastroenterology. 159(5). 1985–1987.e4. 89 indexed citations

Zeuzem, Stefan, Parvez Mantry, Vincent Soriano, et al.. (2016). Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. European Journal of Gastroenterology & Hepatology. 28(8). 923–926. 1 indexed citations

10.

Martin, Robert C.G., Allen Lee Cohn, Bilal Piperdi, et al.. (2016). Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry. The American Journal of Surgery. 213(4). 688–695. 15 indexed citations

11.

Vierling, John M., Masoud Mokhtarani, Robert S. Brown, et al.. (2015). Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 14(6). 903–906.e1. 48 indexed citations

12.

Mantry, Parvez, et al.. (2015). Metastatic Liver Disease - Presenting as Multiple Hepatic Cysts. 1(1). 11–13. 1 indexed citations

13.

Kwo, Paul Y., Parvez Mantry, Eoin Coakley, et al.. (2014). An Interferon-free Antiviral Regimen for HCV after Liver Transplantation. New England Journal of Medicine. 371(25). 2375–2382. 297 indexed citations

14.

Ghabril, Marwan, И. А. Зупанец, John M. Vierling, et al.. (2013). Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration. Clinical Pharmacology in Drug Development. 2(3). 278–284. 21 indexed citations

15.

Kashyap, Randeep, Saman Safadjou, Rui Chen, et al.. (2010). Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database. Journal of Gastrointestinal Surgery. 14(9). 1362–1369. 54 indexed citations

16.

Lodhia, Nilesh, et al.. (2009). Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World Journal of Gastroenterology. 15(12). 1459–1459. 31 indexed citations

17.

Kashyap, Randeep, Adel Bozorgzadeh, Peter L. Abt, et al.. (2008). Stratifying Risk of Biliary Complications in Adult Living Donor Liver Transplantation by Magnetic Resonance Cholangiography. Transplantation. 85(11). 1569–1572. 29 indexed citations

18.

Bozorgzadeh, Adel, Mark S. Orloff, Peter L. Abt, et al.. (2007). Survival Outcomes in Liver Transplantation for Hepatocellular Carcinoma, Comparing Impact of Hepatitis C Versus Other Etiology of Cirrhosis†. Liver Transplantation. 13(6). 807–813. 61 indexed citations

19.

Mantry, Parvez, et al.. (2007). Metachronous Small Bowel Adenocarcinomas Detected by Capsule Endoscopy in a Patient with Hereditary Nonpolyposis Colorectal Cancer. Digestive Diseases and Sciences. 52(4). 1134–1136. 7 indexed citations

20.

Mantry, Parvez, et al.. (2005). Liver Transplantation in Sickle Cell Anemia: A Case of Acute Sickle Cell Intrahepatic Cholestasis and a Case of Sclerosing Cholangitis. Transplantation. 80(11). 1630–1632. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact